DekaBank Deutsche Girozentrale’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-30,700
| Closed | -$1.55M | – | 1427 |
|
|
2022
Q3 | $1.55M | Hold |
30,700
| – | – | ﹤0.01% | 769 |
|
|
2022
Q2 | $760K | Hold |
30,700
| – | – | ﹤0.01% | 936 |
|
|
2022
Q1 | $768K | Buy |
30,700
+2,800
| +10% | +$78.7K | ﹤0.01% | 964 |
|
|
2021
Q4 | $995K | Buy |
27,900
+800
| +3% | +$28.1K | ﹤0.01% | 939 |
|
|
2021
Q3 | $518K | Hold |
27,100
| – | – | ﹤0.01% | 1043 |
|
|
2021
Q2 | $374K | Hold |
27,100
| – | – | ﹤0.01% | 1116 |
|
|
2021
Q1 | $1.33M | Hold |
27,100
| – | – | ﹤0.01% | 823 |
|
|
2020
Q4 | $1.64M | Buy |
27,100
+10,600
| +64% | +$607K | 0.01% | 721 |
|
|
2020
Q3 | $868K | Buy |
+16,500
| New | +$888K | ﹤0.01% | 802 |
|
|
2019
Q4 | – | Sell |
-16,500
| Closed | -$108K | – | 1245 |
|
|
2019
Q3 | $108K | Sell |
16,500
-16,500
| -50% | -$124K | ﹤0.01% | 907 |
|
|
2019
Q2 | $295K | Buy |
33,000
+13,000
| +65% | +$150K | ﹤0.01% | 971 |
|
|
2019
Q1 | $259K | Buy |
20,000
+3,500
| +21% | +$40K | ﹤0.01% | 1008 |
|
|
2018
Q4 | $173K | Sell |
16,500
-3,500
| -18% | -$36.9K | ﹤0.01% | 994 |
|
|
2018
Q3 | $259K | Hold |
20,000
| – | – | ﹤0.01% | 1030 |
|
|
2018
Q2 | $280K | Hold |
20,000
| – | – | ﹤0.01% | 1000 |
|
|
2018
Q1 | $280K | Buy |
+20,000
| New | +$206K | ﹤0.01% | 953 |
|
|
2016
Q2 | – | Sell |
-25,000
| Closed | -$58K | – | 1064 |
|
|
2016
Q1 | $58K | Buy |
25,000
+2,500
| +11% | +$9.11K | ﹤0.01% | 1014 |
|
|
2015
Q4 | $182K | Buy |
22,500
+500
| +2% | +$3.54K | ﹤0.01% | 884 |
|
|
2015
Q3 | $133K | Buy |
22,000
+1,000
| +5% | +$7.23K | ﹤0.01% | 934 |
|
|
2015
Q2 | $173K | Buy |
21,000
+500
| +2% | +$3.97K | ﹤0.01% | 936 |
|
|
2015
Q1 | $155K | Sell |
20,500
-2,500
| -11% | -$19.5K | ﹤0.01% | 949 |
|
|
2014
Q4 | $152K | Sell |
23,000
-2,500
| -10% | -$13.2K | ﹤0.01% | 885 |
|
|
2014
Q3 | $115K | Buy |
25,500
+500
| +2% | +$2.64K | ﹤0.01% | 878 |
|
|
2014
Q2 | $146K | Sell |
25,000
-1,500
| -6% | -$8.42K | ﹤0.01% | 794 |
|
|
2014
Q1 | $176K | Buy |
+26,500
| New | +$184K | ﹤0.01% | 735 |
|
Other funds holding CCXI
DekaBank Deutsche Girozentrale's CCXI Position: Q4 2022 in Review
DekaBank Deutsche Girozentrale sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 30,700 shares — an estimated $1.55M sold.
DekaBank Deutsche Girozentrale first reported a position in CCXI in Q1 2014 and held it in 25 quarters. The position peaked at $1.64M in Q4 2020. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.
- DekaBank Deutsche Girozentrale reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
- DekaBank Deutsche Girozentrale sold 30,700 ChemoCentryx, Inc. shares in Q4 2022, an estimated $1.55M.
- DekaBank Deutsche Girozentrale first reported a position in ChemoCentryx, Inc. in Q1 2014 and held it in 25 quarters.
- DekaBank Deutsche Girozentrale's ChemoCentryx, Inc. position peaked at $1.64M in Q4 2020.
- 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2022, filed 1 Feb 2023.